AlgiSys BioSciences hires investment bank to raise $45M for fish-oil substitute
AlgiSys BioSciences Inc., the biotechnology company in Mayfield Heights, Ohio, has hired an investment bank to raise $45 million in capital to help take its fish oil substitutes to market.
The Series B funding to be raised by Peakstone Securities would be used for commercialization, acquisitions and to hire key executives, AlgiSys BioSciences said in a press release.
The global EPA/DHA (Omega 3) ingredients market is expected to exceed $5.7 billion by 2026, according to a research report by Global…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Mary Vanac Source Type: news
More News: Biotechnology | Fish | Fish Oil | Funding | Health Management | Mergers and Aquisitions | Omega 3